Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition
Camille V. Edwards(Boston University), George J. Murphy(Boston Medical Center), Frederick L. Ruberg(Boston University), Tatiana Prokaeva(Boston University), Josue Villegas-Galaviz(Boston University), Grace Ferri(Boston University), Vaishali Sanchorawala(Boston Medical Center), Richard M. Giadone(Boston University), Gareth J. Morgan(Boston University), Sabrina Ghosh(Boston University), Feiya Wang(Boston University), Elena S. Klimtchuk(Boston University), Andrew Staron(Boston University), Pushpinder Bawa(Boston University), Tinuola B. Ajayi(Boston University)
Cited by 1
Related Papers
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis
|Circulation Heart Failure|2019|560
Systemic immunoglobulin light chain amyloidosis
|Nature Reviews Disease Primers|2018|550